CONFORMED
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
___________________
Date of Report (Date of earliest event reported) April 8, 1998
BIOCONTROL TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 0-10822 25-1229323
(State of other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
300 Indian Springs Road, Indiana, Pennsylvania 15701
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (412) 349-1811
_________________________________________________________________
(Former name or former address,
if changes since last report.)
Item 1. Change in Control of Registrant.
Not applicable.
Item 2. Acquisition or Disposition of Assets.
Not applicable.
Item 3. Bankruptcy or Receivership.
Not applicable.
Item 4. Changes in Registrant's Certifying Accountant
Not applicable.
Item 5. Other Events.
On April 8, 1998 Biocontrol Technology, Inc.
(NASDAQ:BICO) announced today that its recently acquired
subsidiary, International Chemical Technologies, Inc. (ICTI)
entered into a five-year, automatically renewable, joint venture
agreement with Fazio & Associates, Inc. (Fazio) of Bloomfield
Hills, MI, an established firm whose automotive industry customer
list includes Caterpillar, Chrysler, Cummins Engine, Detroit Diesel,
Ford, General Motors, John Deere, Mack, Navistar, and Volvo. The
joint venture will establish a Detroit, MI office for ICTI where
Fazio will be the exclusive representative to the automotive industry
for ICTI's new patented cemkoter metal alloy coating.
Item 6. Resignation of Registrant's Directors. Not Applicable
Item 7. Financial Statement, Pro Forma Financial Information
and Exhibits.
(a) Financial Statements and Businesses Acquired - Not
Applicable.
(b) Pro Forma Financial Information - Not Applicable.
(c) Exhibits - Press Release.
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act
of 1934, the Registrant has duly caused this Report to be signed
on its behalf by the undersigned hereunto duly authorized.
BIOCONTROL TECHNOLOGY, INC.
by /s/ Fred E. Cooper
Fred E. Cooper, CEO
DATED: April 8, 1998
BICO
BIOCONTROL TECHNOLOGY, INC
2275 Swallow Hill Road, Building 2500
Pittsburgh, PA 15220
Press Release
For More Information, Call:
Investors Media
Diane McQuaide Susan Taylor
1.412.429.0673 phone 1.412.279.9455 phone
1.412.279.9690 fax 1.412.279.9447 fax
BIOCONTROL ICTI SUBSIDIARY ENTERS INTO AUTOMOTIVE
INDUSTRY
JOINT VENTURE WITH FAZIO & ASSOCIATES
Pittsburgh, PA - April 8, 1998 - Biocontrol Technology,
Inc. (Nasdaq:BICO) announced today that its recently acquired
subsidiary, International Chemical Technologies, Inc. (ICTI)
entered into a five-year, automatically renewable, joint venture
agreement with Fazio & Associates, Inc. (Fazio) of Bloomfield
Hills, MI, an established firm whose automotive industry customer
list includes Caterpillar, Chrysler, Cummins Engine, Detroit
Diesel, Ford, General Motors, John Deere, Mack, Navistar, and
Volvo. The joint venture will establish a Detroit, MI office
for ICTI where Fazio will be the exclusive representative to the
automotive industry for ICTI's new patented cemkote metal alloy
coating.
Fazio has already presented ICTI's cemkote coating to the GM
Truck Group, GM's Power Train, Detroit Diesel, and Ford Motor
Company.
ICTI will provide technical training and marketing support
as necessary to assist the efforts of Fazio.
Of the new joint venture agreement, Mr. Charles Fazio,
chairman of Fazio & Associates, stated, "Our clients in the
automotive industry have been enthusiastic about the properties
of cemkote and we expect to capture a large portion of the
coating business where those properties enhance the performance
of the clients' products."
Mr. Fazio has over 38 years experience in all aspects of the
automotive business from plant operations to corporate
management, including executive positions at Rockwell
International, Burkhart Randall Automotive Division of Textron
and the Ford Motor Company Sandusky Operation.
Mr. Vince Fazio, president of Fazio and a former Colonel in
the United States Air Force, has over 15 years experience as a
manufacturers representative dealing with major OEM's in the area
of stampings.
Mr. Dean Forester, vice president of engineering at Fazio &
Associates, was formerly manager-engineering of GM Truck and Bus
Group and has over 37 years experience in all design phases and
building of trucks and busses.
Mr. Charles Fazio, Jr., vice president/operations manager of
Fazio, brings over 20 years experience in the product planning
and sales aspects of major automotive programs, including strong
connections to Ford Motor Company.
Cemkote is a uniform, nickel boride metal coating technology
that is an alternative for electroless nickel and the
approximately ten million metric tons of chromium now used
annually worldwide for plating. Cemkote and its application
technology provide extreme hardness, corrosion resistance,
ductility and low friction without the water and airborne toxic
emissions of chromium plating.
The coating is harder than tungsten carbide coatings, hard
chrome and electroless nickel; passes ASTM B117 accelerated and
salt spray tests of two hundred (200) hours; and has a lower
coefficient of friction than electroless nickel, tungsten
carbide, and hard chrome.
Biocontrol Technology, Inc. (www.bico.com) has its
corporate offices in Pittsburgh, PA and is involved in the
development and manufacture of biomedical devices and
environmental products. Its subsidiary, ICTI, is a Florida
corporation established to produce and market the cemkote metal
alloy coating.
